NovoCare
Novo Nordisk’s direct channel: injectable Wegovy at $349/month standard cash ($199 two-month intro at starter doses) and the oral Wegovy pill from $149 — the approved-semaglutide floor that has compressed the compounded discount to double digits at the low end.
Released · Last reviewed · how we verify
Seen against the November 20, 2026 re-read: compounded tirzepatide runs from $85.58 to $399 and semaglutide from $75.58 to $299 per billing cycle, all-in, among programs that print a comparable price, so terms like this one decide whether the advertised number matches the bill. Every definition in this glossary links back to the places in the database and the methodology where the concept does its work.
Its $149 oral floor is the single number that most reshaped the semaglutide comparison this year. Related figures live on the pages this term links to, and every one of them regenerates from the same dataset this definition does.
See the term in action across the price database and the methodology.